Medpace Holdings Stock EBITDA
| MEDP Stock | USD 390.55 0.03 0.01% |
Medpace Holdings fundamentals help investors to digest information that contributes to Medpace Holdings' financial success or failures. It also enables traders to predict the movement of Medpace Stock. The fundamental analysis module provides a way to measure Medpace Holdings' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medpace Holdings stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | 365.1 M | 195.4 M |
Medpace | EBITDA |
Medpace Holdings Company EBITDA Analysis
Medpace Holdings' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Medpace Holdings EBITDA | 365.08 M |
Most of Medpace Holdings' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medpace Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Medpace EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Medpace Holdings is extremely important. It helps to project a fair market value of Medpace Stock properly, considering its historical fundamentals such as EBITDA. Since Medpace Holdings' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Medpace Holdings' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Medpace Holdings' interrelated accounts and indicators.
Click cells to compare fundamentals
Medpace EBITDA Historical Pattern
Today, most investors in Medpace Holdings Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Medpace Holdings' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's ebitda growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Medpace Holdings ebitda as a starting point in their analysis.
Medpace Holdings EBITDA |
| Timeline |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Medpace Ebitda
Ebitda |
|
According to the company disclosure, Medpace Holdings reported earnings before interest,tax, depreciation and amortization of 365.08 M. This is 58.39% lower than that of the Life Sciences Tools & Services sector and 5.24% higher than that of the Health Care industry. The ebitda for all United States stocks is 90.64% higher than that of the company.
Medpace EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medpace Holdings' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medpace Holdings could also be used in its relative valuation, which is a method of valuing Medpace Holdings by comparing valuation metrics of similar companies.Medpace Holdings is currently under evaluation in ebitda category among related companies.
Medpace Holdings ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Medpace Holdings' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Medpace Holdings' managers, analysts, and investors.Environmental | Governance | Social |
Medpace Holdings Institutional Holders
Institutional Holdings refers to the ownership stake in Medpace Holdings that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Medpace Holdings' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Medpace Holdings' value.| Shares | Wellington Management Company Llp | 2023-12-31 | 414.6 K | Bessemer Group Inc | 2023-12-31 | 388.7 K | Dimensional Fund Advisors, Inc. | 2023-12-31 | 373.2 K | Td Global Investment Solutions – Td Epoch | 2023-12-31 | 352.5 K | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 346 K | Btim Corp | 2024-03-31 | 267 K | Los Angeles Capital Management Llc | 2023-12-31 | 254.1 K | T. Rowe Price Associates, Inc. | 2023-12-31 | 252.9 K | Renaissance Technologies Corp | 2023-12-31 | 251.4 K | Vanguard Group Inc | 2023-12-31 | 2.6 M | Blackrock Inc | 2023-12-31 | 2.4 M |
Medpace Fundamentals
| Return On Equity | 0.61 | ||||
| Return On Asset | 0.14 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 11.82 B | ||||
| Shares Outstanding | 30.98 M | ||||
| Shares Owned By Insiders | 17.70 % | ||||
| Shares Owned By Institutions | 85.34 % | ||||
| Number Of Shares Shorted | 902.47 K | ||||
| Price To Earning | 49.07 X | ||||
| Price To Book | 21.90 X | ||||
| Price To Sales | 6.49 X | ||||
| Revenue | 1.89 B | ||||
| Gross Profit | 925.11 M | ||||
| EBITDA | 365.08 M | ||||
| Net Income | 282.81 M | ||||
| Cash And Equivalents | 31.01 M | ||||
| Cash Per Share | 1.00 X | ||||
| Total Debt | 142.12 M | ||||
| Debt To Equity | 0.85 % | ||||
| Current Ratio | 0.41 X | ||||
| Book Value Per Share | 21.72 X | ||||
| Cash Flow From Operations | 433.37 M | ||||
| Short Ratio | 3.81 X | ||||
| Earnings Per Share | 9.80 X | ||||
| Price To Earnings To Growth | 2.68 X | ||||
| Target Price | 448.6 | ||||
| Number Of Employees | 5.8 K | ||||
| Beta | 1.4 | ||||
| Market Capitalization | 12.1 B | ||||
| Total Asset | 1.66 B | ||||
| Retained Earnings | (221.65 M) | ||||
| Working Capital | (331.3 M) | ||||
| Current Asset | 94.72 M | ||||
| Current Liabilities | 134.02 M | ||||
| Net Asset | 1.66 B |
About Medpace Holdings Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medpace Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medpace Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medpace Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Medpace Holdings Piotroski F Score and Medpace Holdings Altman Z Score analysis. To learn how to invest in Medpace Stock, please use our How to Invest in Medpace Holdings guide.Note that the Medpace Holdings information on this page should be used as a complementary analysis to other Medpace Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Medpace Stock analysis
When running Medpace Holdings' price analysis, check to measure Medpace Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medpace Holdings is operating at the current time. Most of Medpace Holdings' value examination focuses on studying past and present price action to predict the probability of Medpace Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medpace Holdings' price. Additionally, you may evaluate how the addition of Medpace Holdings to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Medpace Holdings' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medpace Holdings. If investors know Medpace will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medpace Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.41 | Earnings Share 9.8 | Revenue Per Share 63.975 | Quarterly Revenue Growth 0.177 | Return On Assets 0.1389 |
The market value of Medpace Holdings is measured differently than its book value, which is the value of Medpace that is recorded on the company's balance sheet. Investors also form their own opinion of Medpace Holdings' value that differs from its market value or its book value, called intrinsic value, which is Medpace Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medpace Holdings' market value can be influenced by many factors that don't directly affect Medpace Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medpace Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Medpace Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medpace Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.